ABSTRACT
Proinflammatory IL-17 plays an important role in various diseases and defence against extracellular microorganisms. Healing of leishmaniasis is promoted by Th1/Tc1 cells, whereas Th2/Treg are associated with worsened disease outcome. In addition, high expression of IL-17A in Leishmania-susceptible BALB/c and artificial overexpression of IL-17A in T cells in resistant C57BL/6 mice worsened disease outcome. Since C57BL/6 mice lacking only IL-17A exhibited no phenotype, and IL-17A and IL-17F share similar receptors, but differentially regulate chemokine secretion, we studied mice lacking both IL-17A and IL-17F (IL-17A/F-/- ) in infections with Leishmania major. Interestingly, lesion volumes and parasite burdens were comparable to controls, IL-17A/F-/- mice developed a Th1/Tc1 phenotype, and exhibited normal lesion resolution. Thus, in C57BL/6 mice, secretion of IL-17A and IL-17F does not influence disease progression. It appears that-depending on the genetic background-cytokines of the IL-17 family might be responsible for disease progression primarily in susceptible mice.
Subject(s)
Interleukin-17/immunology , Leishmaniasis/immunology , Th1 Cells/parasitology , Th2 Cells/parasitology , Animals , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/parasitology , Crosses, Genetic , Cytokines/metabolism , Disease Progression , Female , Intraepithelial Lymphocytes/cytology , Intraepithelial Lymphocytes/parasitology , Leishmania/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Phenotype , Th1 Cells/cytology , Th2 Cells/cytologyABSTRACT
Humanized mice represent a suitable preclinical test system for example therapeutic interventions in various disease settings, including infections. Here, we intended to establish such system for cutaneous leishmaniasis by infecting T, B and NK cell-deficient mice adoptively transferred with human peripheral blood mononuclear cells (PBMC). L major infection led to the establishment of parasite lesions harbouring viable parasites and human T cells, but parasite elimination was not seen due to a species-specific activity of T cell-derived human IFNγ. In addition, up to 50% of infected mice succumbed to severe graft-versus-host disease. In summary, even though long-term disease outcome assessments are impossible, this model of humanized mice can be used for studying lesion development and generation of oligoclonal anti-parasite human T cell responses in vivo.
Subject(s)
Adoptive Transfer , Leishmaniasis, Cutaneous/therapy , Leukocytes, Mononuclear/transplantation , T-Lymphocyte Subsets/transplantation , Adoptive Transfer/adverse effects , Animals , Disease Progression , Graft vs Host Disease/etiology , Heterografts , Humans , Interferon-gamma/pharmacology , Leishmaniasis, Cutaneous/parasitology , Macrophages/drug effects , Macrophages/parasitology , Mice , Models, Animal , Species Specificity , T-Lymphocyte Subsets/immunologyABSTRACT
Healing of leishmaniasis-a parasitic skin disease-is associated with high levels of secreted interferon (IFN)γ and IL-12 in resistant C57BL/6 mice and humans. Susceptible BALB/c mice predominantly react with a Th17/Th2/Treg-related immune response and finally succumb to infection. Previously, we showed that BALB/c IL-17A-/- mice are protected against Leishmania (L.) major infections, indicating that IL-17A-predominantly produced by Th17 cells-plays an important role for disease outcome. We now investigated DC-derived cytokines and finally identified IL-23p19 as key cytokine responsible for induction of Leishmania-specific Th17 cells that play an important role for progressive disease in susceptible BALB/c mice.
Subject(s)
Interleukin-23 Subunit p19/genetics , Leishmaniasis, Cutaneous/immunology , Th17 Cells/cytology , Animals , Cytokines/metabolism , Dendritic Cells/metabolism , Disease Progression , Interferon-gamma/metabolism , Leishmania major , Mice , Mice, Inbred BALB C , Polymerase Chain Reaction , Th17 Cells/immunologyABSTRACT
Gender-associated differences in the outcome of infections are well known. Apart from behavior-released differences in their incidence, immunological factors also contribute to disease outcome. The underlying mechanisms are often unknown. Here, we show that in murine experimental leishmaniasis, female mice develop larger skin lesions that harbor significantly more parasites, exhibit increased parasite dissemination to visceral organs associated with a shift towards T helper (Th) 2 immunity with increased levels of IL-4. Antigen presenting cells (APC) responsible for T cell priming, such as macrophages or dendritic cells, were not involved in the process. Additionally, in adoptive transfer experiments, we show that differences in the lymphoid lineage are also not critical for mediating these gender-dependent effects. In summary, neither myeloid nor lymphoid cells contribute to disease outcome against this important human pathogen, but stromal cells influenced by e.g. hormonal effects in addition to other parts of the immune system might play a role.
Subject(s)
Hormones/metabolism , Leishmaniasis, Cutaneous/immunology , Sex , Stromal Cells/immunology , Th2 Cells/immunology , Animals , Cell Differentiation , Cell Lineage , Cells, Cultured , Disease Models, Animal , Disease Progression , Disease Susceptibility , Female , Humans , Interleukin-4/metabolism , Male , Mice , Mice, Inbred C57BL , Myeloid Cells/immunology , Myeloid Cells/parasitology , Stromal Cells/parasitology , Th1-Th2 Balance , Th2 Cells/parasitologyABSTRACT
Jak inhibitors are increasingly used in dermatology. Despite broad inhibitory effects on cytokine signaling cascades, they only modestly increase the risk for infectious diseases. To address the molecular mechanisms underlying this unexpected clinical observation, we investigated how tofacintib (tofa), a first-in-class Jak inhibitor, regulates host defense responses in toll-like receptor 4-activated human macrophages. Specifically, we asked whether tofa inhibits anti-inflammatory IL-10 signaling, thereby counteracting the downregulation of inflammatory, host-protective pathways. We found that tofa blocked macrophage responses to IL-10 at the level of signal transducer and activator of transcription 3 phosphorylation. Furthermore, toll-like receptor 4-induced, autocrine/paracrine IL-10/IL-10R activation promoted the expression of hepcidin, the master regulator of iron metabolism, resulting in intracellular iron sequestration. In contrast, autocrine/paracrine IL-10/IL-10R activation repressed the expression of cathelicidin antimicrobial peptide as well as antigen-presenting molecules, thus together, inducing a pathogen-favoring environment. Although tofa further repressed cathelicidin, it prevented the induction of intracellular HAMP and restored the expression of antigen-presentation molecules in toll-like receptor 4-activated macrophages. Our study supports the concept that induction of IL-10/IL-10R signaling drives a complex immune evasion strategy of intracellular microbes. Moreover, we conclude that tofa has diverging effects on macrophage host response pathways, and we identify the toll-like receptor 4-IL-10-signal transducer and activator of transcription 3-HAMP axis as a potential therapeutic target to counteract immune evasion.
Subject(s)
Janus Kinase Inhibitors , Toll-Like Receptor 4 , Humans , Interleukin-10/metabolism , Iron/metabolism , Janus Kinase Inhibitors/pharmacology , Macrophages/metabolism , Piperidines , Pyrimidines , STAT3 Transcription Factor/metabolism , Toll-Like Receptor 4/metabolismSubject(s)
Disease Susceptibility/immunology , Leishmania major/immunology , Leishmaniasis, Cutaneous/immunology , Mast Cells/immunology , Animals , Disease Models, Animal , Humans , Leishmaniasis, Cutaneous/parasitology , Mast Cells/metabolism , Mice , Mice, Inbred BALB C , Mice, Transgenic , Neutrophil Infiltration , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-kit/metabolism , Th17 Cells/microbiologySubject(s)
Langerhans Cells/immunology , Leishmania major/immunology , Leishmaniasis, Cutaneous/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Antigens, Surface/metabolism , Disease Models, Animal , Humans , Langerhans Cells/metabolism , Lectins, C-Type/metabolism , Leishmaniasis, Cutaneous/parasitology , Leishmaniasis, Cutaneous/pathology , Lymphocyte Count , Mannose-Binding Lectins/metabolism , Mice , Mice, Inbred BALB C , Skin/cytology , Skin/immunology , Skin/parasitology , Skin/pathology , Specific Pathogen-Free OrganismsABSTRACT
T cells can be found in skin under steady-state conditions as well as in inflammatory processes. T cells in skin play an important role in immune homeostasis as well as control of infectious, inflammatory diseases or tumors. In addition, several important and frequent skin diseases such as psoriasis, atopic dermatitis, autoimmune disease, and contact allergy are initiated by T cells. In skin diseases, the majority of antigen-specific T cells can be found in the tissue, not the peripheral blood. Here, we present a protocol suitable for isolation of skin-resident (inflammatory) T cells that can be used for an in-depth characterization of their frequency, function, and role for the respective inflammatory condition.
Subject(s)
Skin/cytology , Skin/immunology , T-Lymphocytes/cytology , Animals , Cell Separation/methods , Dermatitis/immunology , Dermatitis/pathology , Humans , Inflammation/immunology , Inflammation/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , T-Lymphocytes/pathologyABSTRACT
Leishmaniasis is a parasitic infection affecting â¼12 million people worldwide, mostly in developing countries. Treatment options are limited and no effective vaccines exist to date. Natural Killer T (NKT) cells are a conserved innate-like lymphocyte population with immunomodulating effects in various settings. A number of reports state a role of NKT cells in different models of Leishmania infection. Here, we investigated the effect of NKT cells in a physiologically relevant, intradermal low dose infection model. After inoculation of 103 infectious-stage L. major, comparable numbers of skin-immigrating NKT cells in both susceptible BALB/c mice and resistant C57BL/6 mice were noted. Compared to their wild type counterparts, NKT cell-deficient mice on a C57BL/6 background were better able to contain infection with L. major and showed decreased IL-4 production in cytokine analysis performed 5 and 8 weeks after infection. Low doses of the NKT cell stimulating αGalCer analog PBS57 applied at the time of infection led to disease exacerbation in C57BL/6 wild-type, but not NKT-deficient mice. The effect was dependent both on the timing and amount of PBS57 administered. The effect of NKT cell stimulation by PBS57 proved to be IL-4 dependent, as it was neutralized in IL-4-deficient C57BL/6 or anti-IL-4 antibody-treated wild-type mice. In contrast to C57BL/6 mice, administration of PBS57 in susceptible BALB/c mice resulted in an improved course of disease. Our results reveal a strain- and cytokine-dependent regulatory role of NKT cells in the development of immunity to low dose L. major infections. These effects, probably masked in previous studies using higher parasite inocula, should be considered in future therapy and immunization approaches.